Nav1.1 activators (Takeda Pharmaceuticals/Axcelead Drug Discovery Partners)

N/A

Report date: 2025/03/20 15:58:55
NME

Base Information

Drug NameNav1.1 activators (Takeda Pharmaceuticals/Axcelead Drug Discovery Partners)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type I alpha subunit stimulants
TargetsSodium channel protein type I alpha subunit
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdAxcelead Drug Discovery Partners Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A